Launch of About HIV / Pro VICH website
Controlling the HIV epidemic: ambitious funding, expanded workforce, innovations and micro-focus needed
Policy makers’ inaction is leading people to take PrEP ‘in the wild’
No evidence that contaminated nelfinavir led to increased risk of birth abnormalities or cancer
Promising trends continue in UK diagnosis and treatment rates
Dutch model finds PrEP for high-risk gay men is cost-effective at current prices and cost-saving at generic prices
Early infant HIV testing at birth and at 6 weeks of age will save lives, extend life expectancy and is cost-effective for South Africa, study finds
Where would gay men prefer to take their next HIV test?
Two booklets highly commended at BMA Patient Information Awards 2016
